Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)

Saved in:
Bibliographic Details
Main Author: White N.J.
Other Authors: Mahidol University
Format: Letter
Published: 2023
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/85716
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.85716
record_format dspace
spelling th-mahidol.857162023-06-19T00:47:19Z Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA) White N.J. Mahidol University Medicine 2023-06-18T17:47:19Z 2023-06-18T17:47:19Z 2022-07-15 Letter Clinical Infectious Diseases Vol.75 No.2 (2022) , 358 10.1093/cid/ciac024 15376591 10584838 35023549 2-s2.0-85137124619 https://repository.li.mahidol.ac.th/handle/123456789/85716 SCOPUS
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
White N.J.
Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
author2 Mahidol University
author_facet Mahidol University
White N.J.
format Letter
author White N.J.
author_sort White N.J.
title Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
title_short Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
title_full Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
title_fullStr Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
title_full_unstemmed Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
title_sort severe malaria, pascalian therapeutics, and the us food and drug administration (fda)
publishDate 2023
url https://repository.li.mahidol.ac.th/handle/123456789/85716
_version_ 1781415931183890432